Dr. Reddy's legal win expected to lower cost of opioid addiction treatment

After a two-year legal battle, Dr. Reddy's Laboratories has won the right to sell a cheaper version of a best-selling opioid addiction treatment in the U.S., according to Bloomberg.

Dr. Reddy's can now sell a generic version of Suboxone Film. The court victory will bring generic versions of the treatment into the U.S. four years sooner than expected and help reduce the price of a drug that can cost about $500 per month.

Suboxone Film was developed by Indivior, which has hiked the price of the drug four times since 2016. The twice-a-day treatment costs $8.56 a dose.

Dr. Reddy's version began selling last month at $6.33 per dose. Analysts expect prices to drop as much as 70 percent.

The legal battle between Dr. Reddy's and Indivior, which began selling the treatment in August 2016, centers on whether Dr. Reddy's version of Suboxone Film violates a patent.

In June 2018, despite the  patent dispute, Dr. Reddy's launched the product in stores, but had to halt sales  about a month later. In February, the U.S. Supreme Court ruled that Dr. Reddy's could resume sales,  saying that Dr. Reddy's was likely to win its patent case.

More articles on pharmacy:
Harvard gets $100M infusion for drug research from hedge fund
Purdue Pharma CEO: Bankruptcy is 'an option' amid lawsuits
Intermountain CEO Dr. Marc Harrison: How Civica Rx will disrupt the drug industry

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers